candesartan has been researched along with Acute Disease in 16 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Acute Disease: Disease having a short and relatively severe course.
Excerpt | Relevance | Reference |
---|---|---|
"Stroke is a major cause of mortality and disability worldwide." | 6.49 | Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke. ( Ito, T; Kawahara, K; Kikuchi, K; Maruyama, I; Miura, N; Morimoto-Yamashita, Y; Murai, Y; Tanaka, E; Tancharoen, S, 2013) |
"Stroke is a major cause of mortality and disability worldwide." | 2.49 | Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke. ( Ito, T; Kawahara, K; Kikuchi, K; Maruyama, I; Miura, N; Morimoto-Yamashita, Y; Murai, Y; Tanaka, E; Tancharoen, S, 2013) |
"Stroke is a leading cause of adult disability worldwide." | 1.46 | Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension. ( Ahmed, H; Alhusban, A; Ergul, A; Fagan, SC; Ishrat, T; Johnson, MH; Kozak, A; Pillai, B; Sayed, MA, 2017) |
"Acute-on-chronic type B aortic dissection, complicated by aneurysmal dilatation of the thoracic aorta and visceral malperfusion." | 1.33 | Staged endovascular treatment for complicated type B aortic dissection. ( Amukotuwa, SA; McLachlan, CS; Mossop, PJ; Nixon, IK, 2005) |
"Pre-treatment with candesartan resulted in higher survival rate (83%, 10 out of 12 animals) compared with 50% (6 of 12) in control animals and 27% (3 of 11) in animals treated during endotoxinemia." | 1.32 | The angiotensin II receptor blocker candesartan improves survival and mesenteric perfusion in an acute porcine endotoxin model. ( Aneman, A; Ewert, S; Fändriks, L; Laesser, M; Oi, Y, 2004) |
"Candesartan was intravenously administered 30 min before ischemia." | 1.31 | An angiotensin II type 1 receptor blocker, candesartan, increases myocardial apoptosis in rats with acute ischemia-reperfusion. ( Chen, M; Hamada, M; Hiasa, G; Hiwada, K; Ikeda, S; Suzuki, M, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (6.25) | 18.2507 |
2000's | 11 (68.75) | 29.6817 |
2010's | 4 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alhusban, A | 1 |
Kozak, A | 1 |
Pillai, B | 1 |
Ahmed, H | 1 |
Sayed, MA | 1 |
Johnson, MH | 1 |
Ishrat, T | 1 |
Ergul, A | 1 |
Fagan, SC | 1 |
Kikuchi, K | 1 |
Tancharoen, S | 1 |
Ito, T | 1 |
Morimoto-Yamashita, Y | 1 |
Miura, N | 1 |
Kawahara, K | 1 |
Maruyama, I | 1 |
Murai, Y | 1 |
Tanaka, E | 1 |
Jobert, A | 1 |
Rao, N | 1 |
Deayton, S | 1 |
Bennett, GD | 1 |
Brealey, J | 1 |
Nolan, J | 1 |
Carroll, RP | 1 |
Dragun, D | 1 |
Coates, PT | 1 |
Arima, H | 1 |
Chalmers, J | 1 |
Zhang, GX | 1 |
Kimura, S | 1 |
Nishiyama, A | 1 |
Shokoji, T | 1 |
Rahman, M | 1 |
Abe, Y | 1 |
Wuerzner, G | 1 |
Chioléro, A | 1 |
Maillard, M | 1 |
Nussberger, J | 1 |
Brunner, HR | 1 |
Burnier, M | 1 |
Chiclero, A | 1 |
Morton, A | 1 |
Muir, J | 1 |
Lim, D | 1 |
Laesser, M | 1 |
Oi, Y | 1 |
Ewert, S | 1 |
Fändriks, L | 1 |
Aneman, A | 1 |
Schrader, J | 1 |
Diener, HC | 1 |
Lüders, S | 1 |
Mossop, PJ | 1 |
McLachlan, CS | 1 |
Amukotuwa, SA | 1 |
Nixon, IK | 1 |
Audia, P | 1 |
Feinfeld, DA | 1 |
Dubrow, A | 1 |
Winchester, JF | 1 |
Liu, Y | 1 |
Tsuchihashi, T | 1 |
Kagiyama, S | 1 |
Matsumura, K | 1 |
Abe, I | 1 |
Fujishima, M | 1 |
Vallejo, I | 1 |
García Morillo, S | 1 |
Pamies, E | 1 |
González-Jiménez, D | 1 |
Varela, JM | 1 |
Calderón, E | 1 |
Galindo, J | 1 |
González de la Puente, MA | 1 |
Chen, M | 1 |
Hamada, M | 1 |
Hiasa, G | 1 |
Suzuki, M | 1 |
Ikeda, S | 1 |
Hiwada, K | 1 |
Dalmay, F | 1 |
Mazouz, H | 1 |
Allard, J | 1 |
Pesteil, F | 1 |
Achard, JM | 1 |
Fournier, A | 1 |
1 review available for candesartan and Acute Disease
Article | Year |
---|---|
Potential of the angiotensin receptor blockers (ARBs) telmisartan, irbesartan, and candesartan for inhibiting the HMGB1/RAGE axis in prevention and acute treatment of stroke.
Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Benzoates; Biphenyl Compou | 2013 |
1 trial available for candesartan and Acute Disease
Article | Year |
---|---|
Angiotensin II receptor blockade prevents acute renal sodium retention induced by low levels of orthostatic stress.
Topics: Acute Disease; Adult; Angiotensin II; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; B | 2004 |
14 other studies available for candesartan and Acute Disease
Article | Year |
---|---|
Mechanisms of acute neurovascular protection with AT1 blockade after stroke: Effect of prestroke hypertension.
Topics: Acute Disease; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; | 2017 |
Angiotensin II type 1 receptor antibody precipitating acute vascular rejection in kidney transplantation.
Topics: Acute Disease; Administration, Oral; Adrenal Cortex Hormones; Adult; Allografts; Angiotensin II Type | 2015 |
Stroke: blood pressure lowering in acute stroke--scant joy from SCAST.
Topics: Acute Disease; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazoles; Bip | 2011 |
ROS during the acute phase of Ang II hypertension participates in cardiovascular MAPK activation but not vasoconstriction.
Topics: Acute Disease; Adrenergic alpha-Agonists; Angiotensin II; Animals; Antioxidants; Aorta; Benzimidazol | 2004 |
Rash and acute nephritic syndrome due to candesartan.
Topics: Acute Disease; Aged; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Benzimidazole | 2004 |
The angiotensin II receptor blocker candesartan improves survival and mesenteric perfusion in an acute porcine endotoxin model.
Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Cardia | 2004 |
[Treating high blood pressure in acute stroke].
Topics: Acute Disease; Adrenergic alpha-Agonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Conve | 2004 |
Staged endovascular treatment for complicated type B aortic dissection.
Topics: Acute Disease; Adult; Aorta, Thoracic; Aortic Aneurysm, Thoracic; Aortic Dissection; Atenolol; Back | 2005 |
Metformin-induced lactic acidosis and acute pancreatitis precipitated by diuretic, celecoxib, and candesartan-associated acute kidney dysfunction.
Topics: Acidosis, Lactic; Acute Disease; Acute Kidney Injury; Angiotensin II Type 1 Receptor Blockers; Benzi | 2008 |
Central and peripheral mechanisms involved in hypertension induced by chronic inhibition of nitric oxide synthase in rats.
Topics: Acute Disease; Adrenergic alpha-Antagonists; Angiotensin II; Angiotensin Receptor Antagonists; Anima | 1998 |
[Acute hepatitis induced by candesartan].
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Chemica | 2000 |
Candesartan and acute liver injury.
Topics: Acute Disease; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazol | 2000 |
An angiotensin II type 1 receptor blocker, candesartan, increases myocardial apoptosis in rats with acute ischemia-reperfusion.
Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Apoptosis; bcl-2- | 2001 |
Non-AT(1)-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbil.
Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; B | 2001 |